comparemela.com

Oppenheimer & Co. Inc. reduced its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 7.3% in the fourth quarter, Holdings Channel reports. The fund owned 192,330 shares of the biopharmaceutical company’s stock after selling 15,254 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Bristol-Myers Squibb were worth $9,868,000 as of […]

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Bristol Myers Squibb ,Redburn Atlantic ,Pomalyst Imnovid ,Societe Generale ,William Blair ,Securities Exchange Commission ,Bristol Myers Squibb Company ,Associates Corp ,Oppenheimer Co ,Bristol Myers Squibb Company Profile ,Primecap Management Co ,Holdings Channel ,Franklin Resources Inc ,Norges Bank ,Pacer Advisors Inc ,Wells Fargo Company ,Free Report ,Franklin Resources ,Myers Squibb Trading Down ,Myers Squibb ,Get Free Report ,Myers Squibb Company ,Visit Holdingschannel ,Bristol Myers Squibb Daily ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.